A direct-to-consumer genetics and research company.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about 23andMe Holding Co..
The 2 sources with the most insights about 23andMe Holding Co. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Potential for new revenue streams through data monetization and partnerships with biotech firms to identify rare genetic traits for cognitive drugs.
The mention of a speaker using a commercial test points to a strong and growing direct-to-consumer market for DNA testing services, suggesting a long runway for innovation and growth in the industry.
Potential for new revenue streams through data monetization and partnerships with biotech firms to identify rare genetic traits for cognitive drugs.
The mention of a speaker using a commercial test points to a strong and growing direct-to-consumer market for DNA testing services, suggesting a long runway for innovation and growth in the industry.
Other assets that creators frequently mention in the same content as 23andMe Holding Co..
The most active sources covering 23andMe Holding Co. (ME) on Kazuha are The New York Times, Joe Rogan. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about 23andMe Holding Co. (ME) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering 23andMe Holding Co. (ME) most frequently also discuss PRIVATE, PRIVATE, NVO. See the "Discussed alongside" section above for full asset pages.